• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

WHO to update COVID-19 treatment inline with new findings

Ruth Okwumbu-Imafidon by Ruth Okwumbu-Imafidon
June 17, 2020
in Socio Economic
WHO warns countries against rushing to lift coronavirus restrictions

Tedros Adhanom Ghebreyesus

Share on FacebookShare on TwitterShare on Linkedin

Following the discovery of a new cheap drug that helps to reduce mortality cases of COVID-19, the World Health Organisation (WHO) has announced moves to update its treatment guidelines for people infected with COVID-19.

The drug – dexamethasone – which is the product of a UK government-funded clinical trial, was announced on Tuesday by a UK team of scientists.

According to the researchers, it has shown in its preliminary studies and clinical trials, an ability to reduce mortality in severe and critical cases, but not much difference was observed in milder cases.

RelatedStories

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
mpox

Africa requires over $220 million to sustain Mpox response – Africa CDC, WHO 

April 17, 2025

READ MORE: Moderna to get desired result for final COVID-19 vaccine trials in 5 months

The WHO Director-General Tedros Adhanom Ghebreyesus issued a statement to Reuters on Tuesday saying;

“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” adding that a full data analysis of the study will be done to increase understanding of the use of the drug.

Though the studies done so far are preliminary, the researchers behind it suggest that the drug could become a standard medication for severe and critical cases of COVID-19 patients.

NCDC reacts
Meanwhile Nigeria Centre for Disease Control (NCDC) said late on Tuesday that the Nigerian government had not validated the use of Dexamethasone for COVID-19 treatment.

READ MORE: Nigerian pharmacist beats 4,500 contestants across the world to win BNP Paribas’ award 

2/

Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19. In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by @WHO

— NCDC (@NCDCgov) June 16, 2020

“We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone. We will inform the general public on outcomes following scientific review and validation” it read.


Follow us for Breaking News and Market Intelligence.
Tags: COVID-19 PandemicDexamethasoneNCDCTedros Adhanom GhebreyesusWHO
Ruth Okwumbu-Imafidon

Ruth Okwumbu-Imafidon

Ruth Okwumbu has a MSc. and BSc. in Mass Communication from the University of Nigeria, Nsukka, and Delta state university respectively. Prior to her role as analyst at Nairametrics, she had a progressive six year writing career. As a Business Analyst with Narametrics, she focuses on profiles of top business executives, founders, startups and the drama surrounding their successes and challenges. You may contact her via ruth.okwumbu@nairametrics.ng

Related Posts

WHO nominates Prof. Mohamed Janabi as regional director for Africa 
Health

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
mpox
Health

Africa requires over $220 million to sustain Mpox response – Africa CDC, WHO 

April 17, 2025
USAID places all staff globally on administrative leave from February 7, 2025 
Health

USAID withdrawal will disrupt essential services in northeast Nigeria – Stakeholders warn 

March 30, 2025
Global health coalition invests over $250 million in Lassa fever vaccine research  
Health

Lassa fever cases decline in Nigeria, fatality rate remains high at 18.7% – NCDC

March 17, 2025
PenCom seeks bonds to clear N400 billion arrears as retirees groan
Health

Nigeria’s life expectancy at 54 years, below global average – Report

March 11, 2025
Cholera: 2,323 casualties so far in 69,925 cases- NCDC
Health

NCDC confirms Lassa fever death in Nigerian doctor after UK trip, raises surveillance alert

March 10, 2025
Next Post
Brent crude drops to $25, oil demand drops by about 10% of world’s consumption, Brent Crude Oil hits $26, as Nigeria's Sweet Crude demand falls, Oil price pushes up before OPEC meeting, Asian equity markets mixed, NIGERIA OIL: Darker days ahead as Brent falls below production cost, Brent crude drops, as oil traders focus on OPEC+ meeting

Brent Crude slumps, COVID-19 fears dampens oil demand

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

first bank








DUNS

Recent News

  • Alleged $12 Million Money Laundering: EFCC Witness testifies against SunTrust Bank MD, Executive Director 
  • Three cement giants and FIRSTHOLDCO spark rally as ASI shatters 130,000 on the Nigerian stock market 
  • FG to host International Air Show in Abuja in December 

Follow us on social media:

Recent News

Federal High Court, ,

Alleged $12 Million Money Laundering: EFCC Witness testifies against SunTrust Bank MD, Executive Director 

July 17, 2025
Weekly Stock Update: Nigerian Exchange Group record growth w-o-w, up by 0.48%

Three cement giants and FIRSTHOLDCO spark rally as ASI shatters 130,000 on the Nigerian stock market 

July 17, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics